Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Cancer Research
|
February 3, 2022
EZH2 Inhibitors: The Unpacking Revolution
Vera Adema, Simona Colla
Hematology (Amsterdam, Netherlands)
|
March 15, 2005
Angiogenic switch in multiple myeloma
Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Blood
|
March 14, 2024
A road map of relapse in MDS after allo-HSCT
Juan Jose Rodriguez-Sevilla, Simona Colla
Seminars in Hematology
|
October 18, 2024
Inflammation in myelodysplastic syndrome pathogenesis
Juan Jose Rodriguez-Sevilla, Simona Colla
Oncoscience
|
October 3, 2017
RNA processing: a new player of genomic instability in multiple myeloma
Matteo Marchesini, Elena Fiorini, Simona Colla
Acta Bio-Medica : Atenei Parmensis
|
March 31, 2005
Update on the pathogenesis of osteolysis in multiple myeloma patients
Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Blood
|
January 18, 2024
T-cell dysfunctions in myelodysplastic syndromes
Juan Jose Rodriguez-Sevilla, Simona Colla
Experimental Hematology
|
August 17, 2004
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL)
Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Differentiation; Research in Biological Diversity
|
January 15, 2018
Dysfunctional telomeres and hematological disorders
Elena Fiorini, Andrea Santoni, Simona Colla
STAR Protocols
|
October 14, 2022
Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes
Irene Ganan-Gomez, Karen Clise-Dwyer, Simona Colla
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Cancer Research
|
February 3, 2022
EZH2 Inhibitors: The Unpacking Revolution
Vera Adema, Simona Colla
Hematology (Amsterdam, Netherlands)
|
March 15, 2005
Angiogenic switch in multiple myeloma
Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Blood
|
March 14, 2024
A road map of relapse in MDS after allo-HSCT
Juan Jose Rodriguez-Sevilla, Simona Colla
Seminars in Hematology
|
October 18, 2024
Inflammation in myelodysplastic syndrome pathogenesis
Juan Jose Rodriguez-Sevilla, Simona Colla
Oncoscience
|
October 3, 2017
RNA processing: a new player of genomic instability in multiple myeloma
Matteo Marchesini, Elena Fiorini, Simona Colla
Acta Bio-Medica : Atenei Parmensis
|
March 31, 2005
Update on the pathogenesis of osteolysis in multiple myeloma patients
Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Blood
|
January 18, 2024
T-cell dysfunctions in myelodysplastic syndromes
Juan Jose Rodriguez-Sevilla, Simona Colla
Experimental Hematology
|
August 17, 2004
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL)
Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Differentiation; Research in Biological Diversity
|
January 15, 2018
Dysfunctional telomeres and hematological disorders
Elena Fiorini, Andrea Santoni, Simona Colla
STAR Protocols
|
October 14, 2022
Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes
Irene Ganan-Gomez, Karen Clise-Dwyer, Simona Colla
Page
of 10